Mitsubishi UFJ Asset Management
AZN icon

Mitsubishi UFJ Asset Management’s AstraZeneca AZN Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Sell
887
-66
-7% -$12.4K ﹤0.01% 1044
2026
Q1 		$188K Sell
953
-25,174
-96% -$4.85M ﹤0.01% 988
2025
Q4 		$4.78M Buy
26,127
+1,421
+6% +$249K ﹤0.01% 668
2025
Q3 		$3.79M Buy
24,706
+99
+0.4% +$15K ﹤0.01% 684
2025
Q2 		$3.44M Buy
24,607
+1,984
+9% +$278K ﹤0.01% 692
2025
Q1 		$3.33M Buy
22,623
+2,452
+12% +$355K ﹤0.01% 680
2024
Q4 		$2.67M Buy
20,171
+462
+2% +$64.7K ﹤0.01% 715
2024
Q3 		$3.07M Buy
19,709
+1,065
+6% +$172K ﹤0.01% 696
2024
Q2 		$2.91M Buy
18,644
+1,315
+8% +$198K ﹤0.01% 694
2024
Q1 		$2.35M Buy
17,329
+457
+3% +$60.5K ﹤0.01% 709
2023
Q4 		$2.31M Buy
16,872
+720
+4% +$93.6K ﹤0.01% 710
2023
Q3 		$2.19M Buy
16,152
+3,719
+30% +$508K ﹤0.01% 717
2023
Q2 		$1.78M Sell
12,433
-1,934
-13% -$285K ﹤0.01% 753
2023
Q1 		$1.99M Sell
14,367
-390
-3% -$52.5K ﹤0.01% 730
2022
Q4 		$2.05M Buy
14,757
+1,448
+11% +$182K 0.01% 713
2022
Q3 		$1.46M Buy
13,309
+891
+7% +$113K ﹤0.01% 740
2022
Q2 		$1.64M Buy
12,418
+1,256
+11% +$165K 0.01% 739
2022
Q1 		$1.48M Buy
+11,162
New +$1.34M 0.01% 784

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mitsubishi UFJ Asset Management's AZN Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management reduced its AstraZeneca (AZN) stake by 6.9% in Q2 2026, selling an estimated $12.4K and leaving 887 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

Mitsubishi UFJ Asset Management first reported a position in AZN in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.78M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 887 shares of AstraZeneca worth $168K as of Q2 2026.
  • Mitsubishi UFJ Asset Management sold 66 AstraZeneca shares in Q2 2026, an estimated $12.4K.
  • AstraZeneca made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1044 holding.
  • Mitsubishi UFJ Asset Management first reported a position in AstraZeneca in Q1 2022 and has held it in 18 quarters since.
  • Mitsubishi UFJ Asset Management's AstraZeneca position peaked at $4.78M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.